HRTX 悪天候が手術に与える影響

HRTX gross margin will compress by 150-250 basis points in Q1 2026 due to weather-related operational inefficiencies and fixed cost absorption over lower procedure volumes, with margin recovery of 100+ basis points by Q2 2026.

HRTX stock price will experience 5-15% downside within 10 trading days following Q1 2026 earnings announcement due to weather-related revenue miss and reduced guidance, followed by 8-12% recovery within 60 days as management provides mitigation strategy.

Severe weather impact on HRTX Q1 2026 surgical procedures will result in revenue decline of 8-12% compared to Q4 2025, with recovery expected by Q3 2026 as operational capacity normalizes.